[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586973":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":25,"locations":30,"responsibleParty":50,"collaborators":25,"id":53,"slug":54,"hasResults":55,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":25,"eligibilityCriteria":58,"healthyVolunteers":55,"sex":59,"minAge":60,"maxAge":61,"enrollmentInfo":62,"targetDuration":25,"studyType":65,"phases":66,"briefSummary":68,"conditions":69,"keywords":71,"overallStatus":32,"whyStopped":25,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Khyber Teaching Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A, Fluconazole group","EXPERIMENTAL","Group A consists of patients in whom oral fluconazole is given in dose of 300mg once weekly for 2 weeks.",[13],"Drug: Fluconazole",{"label":15,"type":10,"description":16,"interventionNames":17},"Group B, Itraconazole group","Group B consists of patients in whom oral Itraconazole is given in dose of 100mg Twice for 5 days.",[18],"Drug: Itraconazole",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Fluconazole","Oral fluconazole prescribed to group A",[9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Itraconazole","Oral itraconazole prescribed to Group B",[15],[31],{"facility":5,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Peshawar","KPK","25000","Pakistan","PK",{"type":39,"coordinates":40},"Point",[41,42],71.57849,34.008,{"lat":42,"lon":41},[45],{"name":46,"role":47,"phone":48,"phoneExt":25,"email":49},"Hajira Amin","CONTACT","0346 9075951","info@kth.edu.pk",{"type":51,"investigatorFullName":46,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Doctor","100586973","phase-4-comparison-of-efficacy-of-oral-fluconazole-versus-oral-itraconazole-in-the-treatment-of-pityriasis-versicolor-100586973",false,"NCT06922344","Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor","Inclusion Criteria:\n\n* All cases of Pityriasis versicolor\n\nExclusion Criteria:\n\n* Patients with history of chronic renal or liver disease, malignancy , or undergoing any kind of chemotherapy or radiotherapy or having cardiac conduction abnormalities.\n* Patients who received any anti-fungal therapy in the last one month.\n* Pregnant or lactating women.","ALL","18 Years","50 Years",{"count":63,"type":64},106,"ESTIMATED","INTERVENTIONAL",[67],"PHASE4","This study compares the efficacy of two drugs, namely flucanazole and itraconazole for the treatment of a common fungal infection of skin.",[70],"Pityriasis Versicolor",[70,22,27],"2025-04-09",{"date":74,"type":75},"2025-04-10","ACTUAL",{"date":77,"type":75},"2025-03-01",{"date":79,"type":64},"2025-12-31",{"name":5,"class":6},1]